Skip to record
ExecutivesLisa Walters-Hoffert

Executive record

Lisa Walters-Hoffert

Director at KIORA PHARMACEUTICALS INC

Follow record
More
Challenge a Claim

Alpha ID: alpha:person:lisa-walters-hoffertVersion: public-0As of: 2026-10-03

Not yet claimed12 published Claims7 sources
  • Director

Leadership, in context.

Connect capital, control, accountability, and evidence.

Published Claims12Within this recordEvidence sources7Inspect provenance and dates

Explore the record

ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.

Key Claims

Biography

Ms. Walters-Hoffert was co-founder of Dar Bioscience, Inc. (Nasdaq: DARE) and became Chief Financial Officer following its merger with Cerulean Pharma in 2017, serving until January 2024. She has over 25 years of investment banking experience focused on small-cap public companies in technology and life science sectors, including roles at Roth Capital Partners, Citicorp Securities and Oppenheimer & Co.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.